Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

MP Evans offsets lower output with higher prices as H1 profits surge

(Sharecast News) - Shares in Indonesia-focused palm oil producer MP Evans were rising on Monday after the company reported a jump in revenues and profits in the first half as prices increased. Even though output was slightly lower than last year - total crude palm oil production fell 2% while processing volumes were down 3% - turnover for the six months to 30 June was $179.4m, up from $163.7m a year earlier.

The mill-gate crude palm oil (CPO) price was 13% higher than last year at $868 per tonne.

Gross profits totalled $63.4m, up 51% on last year, helped by higher revenues and an increase in the gross margin to 35% from 26%. Operating profits rose 50% to $62.2m, helping the company to raise its interim dividend by 20% to 18p per share.

Margins were supported by a change in input mix with more of the company's own harvest being processed this year, bolstered by lower fertiliser costs due to the timing of application, and a weakening Indonesia currency.

Harvesting levels over the second half so far were up over last year, with total crops harvested rising to 209,700 tonnes from 198,600 tonnes previously.

"The Group's cropping levels during July and August have continued to be higher than during the same period in 2024, despite some dry weather, although some welcome rain returned in the second half of August which bodes well for further crop increases," MP Evans said.

Commenting on the results, chair Peter Hadsley-Chaplin said: "As we move into the second half of the year, the group has added a further 3,000 planted hectares to its portfolio, and both CPO and [palm kernel] prices remain robust."

Shares were up 3.2% at 1,337p by 1127 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.